Status:
UNKNOWN
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
Lead Sponsor:
RenJi Hospital
Conditions:
Diabetic Kidney Disease
Extracellular Matrix Alteration
Eligibility:
All Genders
18+ years
Brief Summary
Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathol...
Eligibility Criteria
Inclusion
- 1\) Age ≥ 18 years old, male or female 2) Patients diagnosed as diabetes kidney disease by renal biopsy
Exclusion
- 1\) Patients combined with non diabetes kidney disease; 2) Patients with kidney transplant failure; 3) Patients undergoing zero point puncture for kidney transplantation; 4) less than 5 glomeruli in the renal puncture sample.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06049550
Start Date
October 1 2023
End Date
October 31 2023
Last Update
September 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.